Literature DB >> 21329653

HMGA1a is involved in specific splice site regulation of human immunodeficiency virus type 1.

Chikayuki Tsuruno1, Kenji Ohe, Madoka Kuramitsu, Takuya Kohma, Youichi Takahama, Yukio Hamaguchi, Isao Hamaguchi, Kazu Okuma.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) utilizes a highly complex splice site regulation system, taking advantage of host proteins, to express its own viral protein in an orderly way. We show here that one of the host proteins, high mobility group A protein 1a (HMGA1a), is involved in splice site regulation of 3' splice site 2 (A2) and 5'splice site 3 (D3) of HIV-1 genomic RNA. shRNA knockdown of HMGA1 in HeLa cells resulting in a decrease of HMGA1 showed a significant decrease of Vpr mRNA. RNA electrophoretic mobility shift assays showed HMGA1a specifically binds to a sequence adjacently upstream D3. In vitro splicing using heterologous pre-mRNA with A2 and D3, showed HMGA1a induced a splicing intermediate which decreased when an RNA decoy of the HMGA1a binding site was added. RT-PCR of in vitro splicing products revealed that HMGA1a induced an incomplete splicing product resulting from usage of A2 but inhibition of D3, which is reminiscent of the splicing pattern necessary for Vpr mRNA formation. HMGA1a interacted with hnRNPA1 shown by coimmunoprecipitation and supershifted U1 snRNP in an RNA electrophoretic mobility shift assay. We conclude that HMGA1a anchors U1 snRNP to inhibit D3 function, and that HMGA1a inhibits hnRNPA1 function on exon splicing silencer of Vpr (ESSV) to activate A2 function. We show here for the first time that HMGA1a is involved in specific splice site regulation of HIV-1.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329653     DOI: 10.1016/j.bbrc.2011.02.059

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.

Authors:  Steffen Erkelenz; Gereon Poschmann; Stephan Theiss; Anja Stefanski; Frank Hillebrand; Marianne Otte; Kai Stühler; Heiner Schaal
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

2.  Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis.

Authors:  Susanne B Breitkopf; Min Yuan; Katja P Helenius; Costas A Lyssiotis; John M Asara
Journal:  Anal Chem       Date:  2015-10-12       Impact factor: 6.986

3.  HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.

Authors:  Sebastian Eilebrecht; Emmanuelle Wilhelm; Bernd-Joachim Benecke; Brendan Bell; Arndt G Benecke
Journal:  RNA Biol       Date:  2013-02-07       Impact factor: 4.652

Review 4.  RNA-Mediated Regulation of HMGA1 Function.

Authors:  Arndt G Benecke; Sebastian Eilebrecht
Journal:  Biomolecules       Date:  2015

5.  Expression Level of HIV-1 Vif Can Be Fluctuated by Natural Nucleotide Variations in the vif-Coding and Regulatory SA1D2prox Sequences of the Proviral Genome.

Authors:  Naoya Doi; Takaaki Koma; Akio Adachi; Masako Nomaguchi
Journal:  Front Microbiol       Date:  2019-11-28       Impact factor: 5.640

6.  A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction.

Authors:  Marek Widera; Frank Hillebrand; Steffen Erkelenz; Ananda Ayyappan Jaguva Vasudevan; Carsten Münk; Heiner Schaal
Journal:  Retrovirology       Date:  2014-08-29       Impact factor: 4.602

7.  HMGA1a Induces Alternative Splicing of the Estrogen Receptor-αlpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5' Splice Site.

Authors:  Kenji Ohe; Shinsuke Miyajima; Tomoko Tanaka; Yuriko Hamaguchi; Yoshihiro Harada; Yuta Horita; Yuki Beppu; Fumiaki Ito; Takafumi Yamasaki; Hiroki Terai; Masayoshi Mori; Yusuke Murata; Makito Tanabe; Ichiro Abe; Kenji Ashida; Kunihisa Kobayashi; Munechika Enjoji; Takashi Nomiyama; Toshihiko Yanase; Nobuhiro Harada; Toshiaki Utsumi; Akila Mayeda
Journal:  Front Mol Biosci       Date:  2018-06-08

8.  High-mobility group A1 proteins may be involved in estrogen receptor status of breast cancer.

Authors:  Yoshihiro Harada; Kenji Ohe
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.